These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 7351628

  • 21. The effects of phencyclidine, ketamine, delta-amphetamine and pentobarbital on schedule-controlled behavior in the mouse.
    Wenger GR, Dews PB.
    J Pharmacol Exp Ther; 1976 Mar; 196(3):616-24. PubMed ID: 1263116
    [Abstract] [Full Text] [Related]

  • 22. Modification of behavioral effects of morphine, meperidine and normeperidine by naloxone and by morphine tolerance.
    Witkin JM, Leander JD, Dykstra LA.
    J Pharmacol Exp Ther; 1983 May; 225(2):275-83. PubMed ID: 6842391
    [Abstract] [Full Text] [Related]

  • 23. Effects of amphetamine-CNS depressant combinations and of other CNS stimulants in four-choice drug discriminations.
    Li M, Wessinger WD, McMillan DE.
    J Exp Anal Behav; 2005 Jul; 84(1):77-97. PubMed ID: 16156138
    [Abstract] [Full Text] [Related]

  • 24. Tolerance to the reinforcing effects of morphine in delta9-tetrahydrocannabinol treated mice.
    Jardinaud F, Roques BP, Noble F.
    Behav Brain Res; 2006 Oct 16; 173(2):255-61. PubMed ID: 16884789
    [Abstract] [Full Text] [Related]

  • 25. Stereospecificity of the discriminative stimulus functions of the dimethylheptyl homologs of 11-hydroxy-delta 8-tetrahydrocannabinol in rats and pigeons.
    Järbe TU, Hiltunen AJ, Mechoulam R.
    J Pharmacol Exp Ther; 1989 Sep 16; 250(3):1000-5. PubMed ID: 2550611
    [Abstract] [Full Text] [Related]

  • 26. Comparison of the effects of naloxone and picrotoxin on schedule-controlled responding in the pigeon: possible GABA-antagonistic effects of naloxone.
    Carter RB, Leander JD.
    J Pharmacol Exp Ther; 1984 Jul 16; 230(1):40-6. PubMed ID: 6747830
    [Abstract] [Full Text] [Related]

  • 27. Morphine, pentazocine and naloxone effects on responding under a multiple schedule of reinforcement in rhesus monkeys and pigeons.
    Downs DA, Woods JH.
    J Pharmacol Exp Ther; 1976 Feb 16; 196(2):298-306. PubMed ID: 815542
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Beta-endorphin elevations in the ventral tegmental area regulate the discriminative effects of Delta-9-tetrahydrocannabinol.
    Solinas M, Zangen A, Thiriet N, Goldberg SR.
    Eur J Neurosci; 2004 Jun 16; 19(12):3183-92. PubMed ID: 15217374
    [Abstract] [Full Text] [Related]

  • 30. The discrimination of drug mixtures using a four-choice procedure in pigeons.
    McMillan DE, Li M.
    Psychopharmacology (Berl); 2002 Nov 16; 164(2):207-13. PubMed ID: 12404084
    [Abstract] [Full Text] [Related]

  • 31. Decreased basal endogenous opioid levels in diabetic rodents: effects on morphine and delta-9-tetrahydrocannabinoid-induced antinociception.
    Williams J, Haller VL, Stevens DL, Welch SP.
    Eur J Pharmacol; 2008 Apr 14; 584(1):78-86. PubMed ID: 18313663
    [Abstract] [Full Text] [Related]

  • 32. Tolerance to the discriminative stimulus effects of Delta(9)-tetrahydrocannabinol.
    Wiley JL, Barrett RL, Balster RL, Martin BR.
    Behav Pharmacol; 1993 Dec 14; 4(6):581-585. PubMed ID: 11224227
    [Abstract] [Full Text] [Related]

  • 33. The role of endogenous opioids in enhancing the antinociception produced by the combination of delta 9-tetrahydrocannabinol and morphine in the spinal cord.
    Pugh G, Smith PB, Dombrowski DS, Welch SP.
    J Pharmacol Exp Ther; 1996 Nov 14; 279(2):608-16. PubMed ID: 8930163
    [Abstract] [Full Text] [Related]

  • 34. Studies on the agonistic activity of delta 9-11-tetrahydrocannabinol in mice, dogs and rhesus monkeys and its interactions with delta 9-tetrahydrocannabinol.
    Beardsley PM, Scimeca JA, Martin BR.
    J Pharmacol Exp Ther; 1987 May 14; 241(2):521-6. PubMed ID: 3033218
    [Abstract] [Full Text] [Related]

  • 35. Retention of sequential drug discriminations under fixed-interval schedules for long time periods without training.
    Li M, McMillan DE.
    Eur J Pharmacol; 2003 Aug 22; 476(1-2):79-85. PubMed ID: 12969752
    [Abstract] [Full Text] [Related]

  • 36. Effects of chemicals on delayed matching behavior in pigeons I: acute effects of drugs.
    McMillan DE.
    Neurotoxicology; 1981 Nov 22; 2(3):485-98. PubMed ID: 6278374
    [Abstract] [Full Text] [Related]

  • 37. Cannabimimetic activity from CP-47,497, a derivative of 3-phenylcyclohexanol.
    Weissman A, Milne GM, Melvin LS.
    J Pharmacol Exp Ther; 1982 Nov 22; 223(2):516-23. PubMed ID: 6290642
    [Abstract] [Full Text] [Related]

  • 38. Behavioral cross-tolerance between repeated intracerebellar nicotine and acute Delta(9)-tetrahydrocannabinol-induced cerebellar ataxia: role of cerebellar nitric oxide.
    Smith AD, Dar MS.
    J Pharmacol Exp Ther; 2007 Jul 22; 322(1):243-53. PubMed ID: 17416741
    [Abstract] [Full Text] [Related]

  • 39. Enhancement mu opioid antinociception by oral delta9-tetrahydrocannabinol: dose-response analysis and receptor identification.
    Cichewicz DL, Martin ZL, Smith FL, Welch SP.
    J Pharmacol Exp Ther; 1999 May 22; 289(2):859-67. PubMed ID: 10215664
    [Abstract] [Full Text] [Related]

  • 40. Changes in opioid and cannabinoid receptor protein following short-term combination treatment with delta(9)-tetrahydrocannabinol and morphine.
    Cichewicz DL, Haller VL, Welch SP.
    J Pharmacol Exp Ther; 2001 Apr 22; 297(1):121-7. PubMed ID: 11259535
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.